TB-500 East Asian Safety Profile Differences: What the Pharmacogenomics Evidence Says
A clinical review of how ethnicity-related pharmacogenomic variation, BMI thresholds, and immune-gene differences may affect TB-500 (thymosin beta-4 active fragment) dosing and safety in East Asian patients.
Read clinical review